Phenergan DM is a combination medication that combines the active ingredients promethazine and dextromethorphan. It is used to treat allergies, colds, and other respiratory illnesses. It is also used to treat nausea and vomiting, as well as to reduce the severity of coughing. This medication is available in both pill and liquid form for oral administration, and is also available as an injection for intramuscular use. Phenergan DM is a safe and effective medication for many medical conditions, but it is important to understand its potential benefits and risks before taking it. This comprehensive guide will provide an overview of Phenergan DM, including its uses, side effects, and precautions.
Phenergan DM is a combination medication that is used to treat a variety of conditions, including allergies, colds, and other respiratory illnesses. It is also used to treat nausea and vomiting, as well as to reduce the severity of coughing. Phenergan DM can be used in both adults and children. Phenergan DM is used to treat allergies by blocking the action of histamine, a chemical released by the body during an allergic reaction. It can also be used to treat colds and other respiratory illnesses by reducing the production of mucus and reducing inflammation in the airways. Phenergan DM is also used to treat nausea and vomiting, as well as to reduce the severity of coughing. It works by blocking the action of acetylcholine, a chemical that causes nausea and vomiting. It also reduces the activity of the vagus nerve, which is responsible for causing coughing.
Like all medications, Phenergan DM can cause side effects. The most common side effects are drowsiness, dizziness, and dry mouth. Other side effects may include headache, nausea, vomiting, constipation, and blurred vision. It is important to be aware of the potential for serious side effects. These include difficulty breathing, an irregular heartbeat, confusion, seizures, and a rapid drop in blood pressure. If you experience any of these side effects, seek medical attention immediately.
Before taking Phenergan DM, it is important to discuss your medical history with your doctor. This medication should not be taken if you have certain medical conditions, such as asthma, glaucoma, heart disease, or liver or kidney disease. It is also important to be aware of potential drug interactions. Phenergan DM should not be taken with certain medications, such as MAO inhibitors, lithium, or certain antibiotics. It is also important to inform your doctor if you are taking any other medications, including over-the-counter drugs, vitamins, or herbal supplements.
Phenergan DM is a safe and effective medication for many medical conditions. It is important to discuss your medical history with your doctor before taking this medication, as well as any potential drug interactions. It is also important to be aware of the potential side effects and seek medical attention if any serious side effects occur. With proper use, Phenergan DM can provide effective relief for many medical conditions.
1.
What is Mohs micrographic surgery? 8 FAQs about Mohs
2.
The Higher the Disability Burden From Disease, the Higher the Suicide Risk
3.
Older Men Increasingly Overtreated for Prostate Cancer, Study Suggests
4.
Anticoagulation for 12 months has been found to improve outcomes in cancer patients with minor blood clots.
5.
Addition of regional nodal irradiation does not decrease rates of invasive breast cancer recurrence, study finds
1.
Biomimetic Nanovesicles for Breast Cancer: Targeting Senescence to Overcome Chemoresistance
2.
Essential Oncology Updates: Diagnosis, Treatment Advances, Tools & Education Resources
3.
Enhancing Cancer Care: From Diagnosis Through Survivorship and Beyond
4.
Omentum Cancer: Causes, Symptoms, and Treatment Options
5.
Acrochordon: What It Is, Causes, And How To Manage This Skin Condition
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation